marina noris
marina noris
Verified email at
TitleCited byYear
Atypical hemolytic–uremic syndrome
M Noris, G Remuzzi
New England Journal of Medicine 361 (17), 1676-1687, 2009
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
M Noris, J Caprioli, E Bresin, C Mossali, G Pianetti, S Gamba, E Daina, ...
Clinical Journal of the American Society of Nephrology 5 (10), 1844-1859, 2010
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
J Caprioli, M Noris, S Brioschi, G Pianetti, F Castelletti, P Bettinaglio, ...
Blood 108 (4), 1267-1279, 2006
Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions
M Noris, M Morigi, R Donadelli, S Aiello, M Foppolo, M Todeschini, ...
Circulation research 76 (4), 536-543, 1995
Hemolytic uremic syndrome
M Noris, G Remuzzi
Journal of the American Society of Nephrology 16 (4), 1035-1050, 2005
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
P Ruggenenti, M Noris, G Remuzzi
Kidney international 60 (3), 831-846, 2001
Thrombomodulin mutations in atypical hemolytic–uremic syndrome
M Delvaeye, M Noris, A De Vriese, CT Esmon, NL Esmon, G Ferrell, ...
New England Journal of Medicine 361 (4), 345-357, 2009
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells
F Casiraghi, N Azzollini, P Cassis, B Imberti, M Morigi, D Cugini, ...
The Journal of Immunology 181 (6), 3933-3946, 2008
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
T Manuelian, J Hellwage, S Meri, J Caprioli, M Noris, S Heinen, M Jozsi, ...
The Journal of clinical investigation 111 (8), 1181-1190, 2003
Mechanisms of disease: pre-eclampsia
M Noris, N Perico, G Remuzzi
Nature Reviews Nephrology 1 (2), 98, 2005
Familial haemolytic uraemic syndrome and an MCP mutation
M Noris, S Brioschi, J Caprioli, M Todeschini, E Bresin, F Porrati, ...
The Lancet 362 (9395), 1542-1547, 2003
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
M Noris, F Mescia, G Remuzzi
Nature Reviews Nephrology 8 (11), 622, 2012
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease
J Caprioli, F Castelletti, S Bucchioni, P Bettinaglio, E Bresin, G Pianetti, ...
Human molecular genetics 12 (24), 3385-3395, 2003
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20
Journal of the American Society of Nephrology 12 (2), 297-307, 2001
The hemolytic uremic syndrome
G Remuzzi, P Ruggenenti
Kidney international 48 (1), 2-19, 1995
Overview of complement activation and regulation
M Noris, G Remuzzi
Seminars in nephrology 33 (6), 479-492, 2013
Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension
M Noris, A Benigni, P Boccardo, S Aiello, F Gaspari, M Todeschini, ...
Kidney international 44 (2), 445-450, 1993
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype
E Bresin, E Rurali, J Caprioli, P Sanchez-Corral, V Fremeaux-Bacchi, ...
Journal of the American Society of Nephrology 24 (3), 475-486, 2013
Factor H family proteins: on complement, microbes and human diseases
PF Zipfel, C Skerka, J Hellwage, ST Jokiranta, S Meri, V Brade, P Kraiczy, ...
Biochemical Society Transactions 30 (6), 971-978, 2002
Regulatory T cells and T cell depletion: role of immunosuppressive drugs
M Noris, F Casiraghi, M Todeschini, P Cravedi, D Cugini, G Monteferrante, ...
Journal of the American Society of Nephrology 18 (3), 1007-1018, 2007
The system can't perform the operation now. Try again later.
Articles 1–20